Trials / Completed
CompletedNCT00986921
Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks
Mifepristone vs. Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Boston University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Women who are requesting pregnancy termination at 14-16 weeks, who would normally have osmotic dilator insertion the day before their procedure, would be asked if they wanted to participate. Participants would be randomized to two groups: first, dilator insertion as usual, or second, mifepristone taken the day before the procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mifepristone 200 mg | mifepristone would be given the day before the procedure |
| DEVICE | osmotic dilator insertion | osmotic dilators (3-6) would be inserted as usual the day before the procedure |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2009-09-30
- Last updated
- 2014-01-31
- Results posted
- 2013-12-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00986921. Inclusion in this directory is not an endorsement.